• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

计算假设:肝内功能异质性如何影响游离脂肪酸诱导的非酒精性脂肪性肝病(NAFLD)的级联进展。

Computational Hypothesis: How Intra-Hepatic Functional Heterogeneity May Influence the Cascading Progression of Free Fatty Acid-Induced Non-Alcoholic Fatty Liver Disease (NAFLD).

机构信息

Institute of Biochemistry, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Charitéplatz 1, 10117 Berlin, Germany.

Institute for Imaging Science and Computational Modelling in Cardiovascular Medicine, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Augustenburger Platz 1, 13353 Berlin, Germany.

出版信息

Cells. 2021 Mar 5;10(3):578. doi: 10.3390/cells10030578.

DOI:10.3390/cells10030578
PMID:33808045
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7999144/
Abstract

Non-Alcoholic Fatty Liver Disease (NAFLD) is the most common type of chronic liver disease in developed nations, affecting around 25% of the population. Elucidating the factors causing NAFLD in individual patients to progress in different rates and to different degrees of severity, is a matter of active medical research. Here, we aim to provide evidence that the intra-hepatic heterogeneity of rheological, metabolic and tissue-regenerating capacities plays a central role in disease progression. We developed a generic mathematical model that constitutes the liver as ensemble of small liver units differing in their capacities to metabolize potentially cytotoxic free fatty acids (FFAs) and to repair FFA-induced cell damage. Transition from simple steatosis to more severe forms of NAFLD is described as self-amplifying process of cascading liver failure, which, to stop, depends essentially on the distribution of functional capacities across the liver. Model simulations provided the following insights: (1) A persistently high plasma level of FFAs is sufficient to drive the liver through different stages of NAFLD; (2) Presence of NAFLD amplifies the deleterious impact of additional tissue-damaging hits; and (3) Coexistence of non-steatotic and highly steatotic regions is indicative for the later occurrence of severe NAFLD stages.

摘要

非酒精性脂肪性肝病(NAFLD)是发达国家最常见的慢性肝病,影响大约 25%的人口。阐明导致个体患者 NAFLD 以不同速度和不同严重程度进展的因素,是医学研究的一个活跃领域。在这里,我们旨在提供证据表明,肝脏内的流变学、代谢和组织再生能力的异质性在疾病进展中起着核心作用。我们开发了一个通用的数学模型,将肝脏视为具有不同代谢潜在细胞毒性游离脂肪酸(FFAs)和修复 FFA 诱导的细胞损伤能力的小肝单位的集合。从单纯性脂肪变性到更严重的 NAFLD 形式的转变被描述为肝衰竭的级联自我放大过程,要停止该过程,主要取决于肝脏内功能能力的分布。模型模拟提供了以下见解:(1)持续高水平的血浆 FFA 足以使肝脏经历不同阶段的 NAFLD;(2)NAFLD 的存在放大了其他组织损伤的有害影响;(3)非脂肪变性和高度脂肪变性区域共存提示随后发生严重的 NAFLD 阶段。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a3b/7999144/1cf30240887f/cells-10-00578-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a3b/7999144/7f9d37fce79e/cells-10-00578-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a3b/7999144/f7ef4ebb0262/cells-10-00578-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a3b/7999144/3f8402d73872/cells-10-00578-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a3b/7999144/3fd6b4379a7b/cells-10-00578-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a3b/7999144/e7982d7a1bff/cells-10-00578-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a3b/7999144/82d74344e51e/cells-10-00578-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a3b/7999144/1cf30240887f/cells-10-00578-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a3b/7999144/7f9d37fce79e/cells-10-00578-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a3b/7999144/f7ef4ebb0262/cells-10-00578-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a3b/7999144/3f8402d73872/cells-10-00578-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a3b/7999144/3fd6b4379a7b/cells-10-00578-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a3b/7999144/e7982d7a1bff/cells-10-00578-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a3b/7999144/82d74344e51e/cells-10-00578-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a3b/7999144/1cf30240887f/cells-10-00578-g007.jpg

相似文献

1
Computational Hypothesis: How Intra-Hepatic Functional Heterogeneity May Influence the Cascading Progression of Free Fatty Acid-Induced Non-Alcoholic Fatty Liver Disease (NAFLD).计算假设:肝内功能异质性如何影响游离脂肪酸诱导的非酒精性脂肪性肝病(NAFLD)的级联进展。
Cells. 2021 Mar 5;10(3):578. doi: 10.3390/cells10030578.
2
The role of hepassocin in the development of non-alcoholic fatty liver disease.海帕西菌素在非酒精性脂肪性肝病发展中的作用。
J Hepatol. 2013 Nov;59(5):1065-72. doi: 10.1016/j.jhep.2013.06.004. Epub 2013 Jun 18.
3
Lycopus lucidus Turcz. ex Benth. Attenuates free fatty acid-induced steatosis in HepG2 cells and non-alcoholic fatty liver disease in high-fat diet-induced obese mice.荆条提取物减轻 HepG2 细胞游离脂肪酸诱导的脂肪变性和高脂饮食诱导肥胖小鼠的非酒精性脂肪肝。
Phytomedicine. 2019 Mar 1;55:14-22. doi: 10.1016/j.phymed.2018.07.008. Epub 2018 Jul 18.
4
[Role of metabolic lipases and lipotoxicity in the development of non-alcoholic steatosis and non-alcoholic steatohepatitis].[代谢性脂肪酶和脂毒性在非酒精性脂肪变性和非酒精性脂肪性肝炎发生发展中的作用]
Clin Investig Arterioscler. 2016 Jan-Feb;28(1):47-61. doi: 10.1016/j.arteri.2015.03.003. Epub 2015 Jun 3.
5
Effects of chronic HBV infection on lipid metabolism in non-alcoholic fatty liver disease: A lipidomic analysis.慢性乙型肝炎病毒感染对非酒精性脂肪性肝病患者脂代谢的影响:脂质组学分析。
Ann Hepatol. 2021 Sep-Oct;24:100316. doi: 10.1016/j.aohep.2021.100316. Epub 2021 Jan 28.
6
Understanding lipotoxicity in NAFLD pathogenesis: is CD36 a key driver?理解非酒精性脂肪性肝病发病机制中的脂毒性:CD36 是关键驱动因素吗?
Cell Death Dis. 2020 Sep 25;11(9):802. doi: 10.1038/s41419-020-03003-w.
7
Disturbed Vitamin A Metabolism in Non-Alcoholic Fatty Liver Disease (NAFLD).非酒精性脂肪性肝病 (NAFLD) 中维生素 A 代谢紊乱。
Nutrients. 2017 Dec 29;10(1):29. doi: 10.3390/nu10010029.
8
Exposure to environmental contaminants is associated with altered hepatic lipid metabolism in non-alcoholic fatty liver disease.暴露于环境污染物与非酒精性脂肪性肝病患者肝内脂质代谢改变有关。
J Hepatol. 2022 Feb;76(2):283-293. doi: 10.1016/j.jhep.2021.09.039. Epub 2021 Oct 7.
9
β-patchoulene improves lipid metabolism to alleviate non-alcoholic fatty liver disease via activating AMPK signaling pathway.β-石竹烯通过激活 AMPK 信号通路改善脂质代谢,从而缓解非酒精性脂肪肝疾病。
Biomed Pharmacother. 2021 Feb;134:111104. doi: 10.1016/j.biopha.2020.111104. Epub 2020 Dec 16.
10
Post-weaning exposure to high-sucrose diet induces early non-alcoholic fatty liver disease onset and progression in male mice: role of dysfunctional white adipose tissue.断奶后暴露于高糖饮食会诱导雄性小鼠早期非酒精性脂肪性肝病的发生和进展:功能失调的白色脂肪组织的作用。
J Dev Orig Health Dis. 2020 Oct;11(5):509-520. doi: 10.1017/S2040174420000598. Epub 2020 Jun 29.

引用本文的文献

1
Emodin induced hepatic steatosis in BALb/c mice by modulating the gut microbiota composition and fatty acid metabolism.大黄素通过调节肠道微生物群组成和脂肪酸代谢诱导BALb/c小鼠发生肝脂肪变性。
Front Pharmacol. 2024 Dec 24;15:1516272. doi: 10.3389/fphar.2024.1516272. eCollection 2024.
2
A Quantitative Systems Pharmacology Model of Liver Lipid Metabolism for Investigation of Non-Alcoholic Fatty Liver Disease.用于研究非酒精性脂肪性肝病的肝脏脂质代谢定量系统药理学模型。
Front Pharmacol. 2022 Jul 19;13:910789. doi: 10.3389/fphar.2022.910789. eCollection 2022.
3
Applications of Quantitative Systems Pharmacology (QSP) in Drug Development for NAFLD and NASH and Its Regulatory Application.

本文引用的文献

1
A low coefficient of variation in hepatic triglyceride concentration in an inbred rat strain.同窝系大鼠肝甘油三酯浓度的变异系数低。
Lipids Health Dis. 2020 Jun 16;19(1):137. doi: 10.1186/s12944-020-01320-9.
2
Functional Consequences of Metabolic Zonation in Murine Livers: Insights for an Old Story.代谢分区在小鼠肝脏中的功能后果:一个古老故事的新视角。
Hepatology. 2021 Feb;73(2):795-810. doi: 10.1002/hep.31274. Epub 2020 Nov 7.
3
Variation in diagnostic NAFLD/NASH read-outs in paired liver samples from rodent models.来自啮齿动物模型的配对肝脏样本中诊断非酒精性脂肪性肝病/非酒精性脂肪性肝炎结果的差异。
定量系统药理学(QSP)在非酒精性脂肪性肝病(NAFLD)和非酒精性脂肪性肝炎(NASH)药物开发中的应用及其监管应用。
Pharm Res. 2022 Aug;39(8):1789-1802. doi: 10.1007/s11095-022-03295-x. Epub 2022 May 24.
J Pharmacol Toxicol Methods. 2020 Jan-Feb;101:106651. doi: 10.1016/j.vascn.2019.106651. Epub 2019 Nov 13.
4
Something old, something new: liver injury associated with total parenteral nutrition therapy and immune checkpoint inhibitors.旧的问题,新的挑战:肠外营养治疗和免疫检查点抑制剂相关肝损伤。
Hum Pathol. 2020 Feb;96:39-47. doi: 10.1016/j.humpath.2019.10.007. Epub 2019 Oct 26.
5
Gene expression across mammalian organ development.哺乳动物器官发育过程中的基因表达。
Nature. 2019 Jul;571(7766):505-509. doi: 10.1038/s41586-019-1338-5. Epub 2019 Jun 26.
6
Dynamic Metabolic Zonation of the Hepatic Glucose Metabolism Is Accomplished by Sinusoidal Plasma Gradients of Nutrients and Hormones.肝脏葡萄糖代谢的动态代谢分区是由营养物质和激素的窦状血浆梯度实现的。
Front Physiol. 2018 Dec 12;9:1786. doi: 10.3389/fphys.2018.01786. eCollection 2018.
7
Identification of spatially associated subpopulations by combining scRNAseq and sequential fluorescence in situ hybridization data.通过整合单细胞RNA测序和连续荧光原位杂交数据来鉴定空间相关亚群。
Nat Biotechnol. 2018 Oct 29. doi: 10.1038/nbt.4260.
8
Identification of Protein Abundance Changes in Hepatocellular Carcinoma Tissues Using PCT-SWATH.使用PCT-SWATH技术鉴定肝细胞癌组织中的蛋白质丰度变化
Proteomics Clin Appl. 2019 Jan;13(1):e1700179. doi: 10.1002/prca.201700179. Epub 2018 Nov 19.
9
Multi-scale, whole-system models of liver metabolic adaptation to fat and sugar in non-alcoholic fatty liver disease.非酒精性脂肪性肝病中肝脏对脂肪和糖代谢适应的多尺度全系统模型
NPJ Syst Biol Appl. 2018 Aug 20;4:33. doi: 10.1038/s41540-018-0070-3. eCollection 2018.
10
New Aspects of Lipotoxicity in Nonalcoholic Steatohepatitis.非酒精性脂肪性肝炎中脂毒性的新方面。
Int J Mol Sci. 2018 Jul 13;19(7):2034. doi: 10.3390/ijms19072034.